Free Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • United States Trump critical of FDA in announcement of health secretary nomination ...
  • Indonesia Members of associations and government speak on plain packaging draft regulation ...
  • World WHO World No Tobacco Day to focus on tactics used to make products attractive ...
  • Lithuania Parliament approves tightening sanctions for under-age tobacco sales ...
  • Peru The bill regulating tobacco and nic products now in force ...
  • Russia Support for bill to block info on online sales of tobacco products ...
  • Spain Government to hike tax on tobacco products and introduce pouch tax ...
  • Vietnam Ministry of Health proposes HTP ban ...
  • Netherlands All oral nicotine products banned from 1st January ...
  • Ukraine Electronic excise system to go live in March 2025 ...
  • Thailand Committee pushes policy to reduce smoking rates ...
  • Vietnam Ministry of Industry and Trade supports e-cig ban ...
View all
News analysis

Drug Establishment Licence doesn’t let TJP Labs sell pouches in Canada – yet

Written by || 19th October 2022 || News analysis | Modern oral | Regulation and legislation | GeographiesCanada North America

A Canadian company says Health Canada’s decision to grant it a Drug Establishment Licence (DEL) is another step towards its goal of eventually selling nicotine pouches in Canada – though the department itself has confirmed to TobaccoIntelligence that it does not currently permit them to do so.

David Richmond-Peck, CEO of TJP Labs, said: “We carry a Health Canada drug licence which, we believe, would be a requirement for companies wanting to produce modern oral products in the future.”

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Author default picture

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.